omica.ai
New York
About omica.ai
Omica turns real-world clinical data into structured training infrastructure for biomedical AI. We partner with hospitals and labs to extract, standardize, and validate multimodal patient data ’ including notes, pathology, imaging, and genomics. Our pipeline combines automation with clinical oversight to produce longitudinal, de-identified datasets ready for research and model training. Through our platform, Atlas, clients can define cohorts, access structured outputs, and power applications in real-world evidence and predictive modeling. Our data assets are already used by leading AI diagnostics companies and global pharma teams building the next generation of clinical tools.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2024)
- Website: omica.bio
- Phone: [email protected]
Industries & Categories
Analytics, Artificial Intelligence (AI), Bioinformatics, Data Collection and Labeling, Data Integration
Social Profiles
Canonical: https://fsome.com/organization/omica-ai-8085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.